
    
      In the study NextGen SE (single-center, prospective, open diagnostic study) are on-hand a
      cohort comprising each 50 pediatric and 50 adult patients, and in which there are an unclear
      movement disorder or an unclear cognitive disorder, examines the following questions:

      Primary:

        -  Number of diagnoses made by next-generation sequencing (NGS)

      Secondary:

        1. Restriction of the quality of life by unclear disease

        2. Cost of not purposeful preliminary diagnostics (beyond the minimal diagnostic data of
           the diagnosis to therapy and follow-up examinations

        3. Time to diagnosis
    
  